Robert Naclerio to Pollen
This is a "connection" page, showing publications Robert Naclerio has written about Pollen.
Connection Strength
1.121
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.110
-
Pollen lipidomics: lipid profiling exposes a notable diversity in 22 allergenic pollen and potential biomarkers of the allergic immune response. PLoS One. 2013; 8(2):e57566.
Score: 0.101
-
Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier. PLoS One. 2013; 8(1):e53337.
Score: 0.100
-
The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
Score: 0.096
-
The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
Score: 0.093
-
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
Score: 0.087
-
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1986 Nov; 134(5):1102.
Score: 0.065
-
Effect of seasonal ragweed exposure on immunoglobulin E antiragweed antibodies in cultures of peripheral mononuclear cells, plasma and nasal secretions. Int Arch Allergy Appl Immunol. 1985; 78(3):225-32.
Score: 0.057
-
Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
Score: 0.038
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.035
-
A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
Score: 0.034
-
Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol. 1992 Feb; 89(2):519-29.
Score: 0.023
-
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol. 1991 Jul; 88(1):27-32.
Score: 0.022
-
The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
Score: 0.022
-
Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol. 1990 Dec; 86(6 Pt 1):851-61.
Score: 0.022
-
An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Nov-Dec; 31(6):483-92.
Score: 0.021
-
Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
Score: 0.021
-
Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
Score: 0.021
-
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
Score: 0.021
-
Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989 Oct; 84(4 Pt 1):492-501.
Score: 0.020
-
Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
Score: 0.020
-
Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
Score: 0.020
-
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
Score: 0.017
-
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
Score: 0.017
-
Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):874-6.
Score: 0.016
-
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
Score: 0.015
-
Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
Score: 0.004
-
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
Score: 0.003